This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name : 
EMD Millipore
other brands : 
Oncogene Research Products, Calbiochem, Novagen, Merck, Upstate Biotechnology, Chemicon, LINCO, Novabiochem, Guava
product type : 
antibody
product name : 
Hepatitis B Virus Antibody, X-Protein, a.a. 50-88, clone 146
catalog : 
MAB8429
quantity : 
100 µg
clonality : 
monoclonal
host : 
mouse
conjugate : 
nonconjugated
clone name : 
146
reactivity : 
Hepatitis B virus
application : 
western blot, ELISA, immunocytochemistry
product information
Catalog Number : 
MAB8429
Subcategory : 
Infectious Diseases
Product Name : 
Anti-Hepatitis B Virus Antibody, X-Protein, a.a. 50-88, clone 146
Product Type : 
Antibodies
Clonality : 
Monoclonal Antibody
Host Name : 
Mouse
Antigen : 
Hepatitis B Virus
Clone : 
146
Conjugate : 
Purified
Isotype : 
IgG1κ
Product Description : 
Anti-Hepatitis B Virus Antibody, X-Protein, a.a. 50-88, clone 146
Cross Reactivity : 
Human
ALT Names : 
Trans-Activator X Gene Product
Immunogen : 
Peptide cooresponding to amino acids 50-88 of human HBV-X protein {gahlslrglpvcafssagpca lrltsvrrmettvnahqv}
Specificity : 
Reacts with Hbx protein (trans-activator X gene product)  of hepatitis B virus (epitope recognized - amino acid positions 50-88). 
SPECIES REACTIVITIES: 
Reacts only with human HBV
Package Size : 
100 µg
Uses : 
ELISA;Western Blotting;Immunocytochemistry
Storage : 
Maintain at 2-8°C in undiluted aliquots for up to 12 months. Avoid repeated freeze/thaw cycles.
company information
EMD Millipore
290 Concord Road
Billerica, Massachusetts 01821
Billerica, Massachusetts 01821
bioscienceshelp@emdchemical.com
https://www.emdmillipore.com888-854-3417
headquarters: United States
EMD Millipore is the Life Science division of Merck KGaA of Darmstadt, Germany
Hundreds of New Antibodies in the areas of: 
View all the new antibodies at www.emdmillipore.com.
Hundreds of New Antibodies in the areas of:
| 
 | 
 | 
questions and comments
